Sage Journals: Discover world-class research

Open access

Case report

First published 2025

Combined autologous hematopoietic stem cell transplantation and CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma with TP53 mutation: A case report

Ziyi Cai, Dongmei Zou, Qiang Ma [...]

Sage Open Medical Case Reports

Retricted access

Case report

First published 2023-1

Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis

Donald C Moore, Keren A Eagers, Amanda Janes [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2022-12

New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Donald C. Moore, Matthew R. Peery, Katherine A. Tobon [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Open access

Review article

First published 2022

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a review of clinical data

Fateeha Furqan, Mehdi Hamadani

Therapeutic Advances in Hematology

Open access

Case report

First published 2024-7

Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression,Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge

Fouad El Dana, Sofia Alexandra Garces Narvaez, Nader K. El-Mallawany [...]

Pediatric and Developmental Pathology

Open access

Review article

First published 2022

Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma

Fabian Frontzek, Imke Karsten, Norbert Schmitz [...]

Therapeutic Advances in Hematology

Retricted access

Review article

First published 2022-4

Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma

James A. Davis, Abigail Shockley, Ashley E. Glode

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2025

The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review

Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti [...]

Technology in Cancer Research & Treatment

Free access

Research article

First published 2018-4

Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant

Joshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki [...]

Therapeutic Advances in Hematology

Search results